Latest Bone density Stories
The International Osteoporosis Foundation (IOF), in cooperation with medical and patient societies from throughout Latin America, has today published a landmark report which compiles osteoporosis-related data on 14 countries and the region as a whole.
The Food and Drug Administration (FDA) announced today that physicians should reassess patients with osteoporosis who are being treated with a class of drugs called bisphosphonates after three to five years of therapy to determine whether they should continue treatment.
Continuing a popular but controversial treatment for osteoporosis could reduce spine fracture risk for a particular group of patients, but others could see little to no change if they discontinue it.
Women who go through the menopause early are nearly twice as likely to suffer from osteoporosis in later life.
Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have identified the genetic variations that are believed to cause osteoporosis.
Millions of people around the world are prescribed glucocorticoids for a wide variety of inflammatory conditions, including, rheumatoid arthritis, asthma and inflammatory bowel diseases.
Researchers from the MRC Lifecourse Epidemiology Unit, University of Southampton, have presented evidence that early growth predicts the size, mineralization, shape and strength of the hip bone in childhood.
- Emitting flashes of light; glittering.